<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996342</url>
  </required_header>
  <id_info>
    <org_study_id>CVDcohort</org_study_id>
    <nct_id>NCT04996342</nct_id>
  </id_info>
  <brief_title>A Cohort Study of Chronic Cardiovascular Diseases</brief_title>
  <official_title>A Cohort Study of Chronic Cardiovascular Diseases in the Department of Cardiology, Peking University First Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective cohort study aims to establish cohorts of patients with chronic&#xD;
      cardiovascular disease, including refractory and secondary hypertension, coronary heart&#xD;
      disease, atrial fibrillation, ventricular arrhythmias, structural heart disease, pulmonary&#xD;
      hypertension, heart failure and rare diseases of the cardiovascular system, and patients with&#xD;
      implantations of cardiac pacemaker, in order to dynamically describe the population&#xD;
      characteristics, diagnosis and treatment status and long-term prognosis and analyze the&#xD;
      factors affecting the choice of treatment plan, long-term management quality and clinical&#xD;
      prognosis of these patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>5 year</time_frame>
    <description>Time to the first occurence of Any cause death, myocardial infarction, or Stroke</description>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Cohort Studies</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in the department of Cardiology or outpatient department of Peking&#xD;
        University First Hospital will be enrolled if they are aged ≥18 years old, meet the&#xD;
        inclusion criteria of each cohort for the 9 specific chronic cardiovascular disease, and&#xD;
        need long-term follow-up according to the judgment of doctors after informed consent.&#xD;
        Patients will be included in different disease-specific cohorts based on the disease status&#xD;
        and treatment, including hypertension, coronary heart disease, arrhythmia (atrial&#xD;
        fibrillation, ventricular arrhythmia), pacemaker surgery, structural heart disease, and&#xD;
        heart failure, etc. The same patient who meets the inclusion criteria of multiple specific&#xD;
        diseases can be entered into different cohorts at the same time. It is expected to enroll&#xD;
        1500 to 2000 patients per year.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        This study includes 9 disease-specific cohorts. The specific inclusion and exclusion&#xD;
        criteria are as following:&#xD;
&#xD;
          1. Refractory and secondary hypertension&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients diagnosed as refractory hypertension and/or secondary hypertension&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
          2. Coronary heart disease&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients undergoing coronary angiography and interventional therapy in the cath&#xD;
                  lab&#xD;
&#xD;
               -  Patients undergoing coronary angiography and functional assessment in the cath&#xD;
                  lab&#xD;
&#xD;
               -  Patients diagnosed as acute myocardial infarction&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
               -  Regular return visits not available&#xD;
&#xD;
          3. Atrial fibrillation&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  PAtrial fibrillation diagnosed by electrocardiogram or holter (duration &gt;30&#xD;
                  seconds)&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
               -  New-onset atrial fibrillation during the perioperative period of major surgery&#xD;
&#xD;
          4. Ventricular arrhythmias&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients diagnosed as ventricular tachycardia, ventricular premature beat&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
               -  A transient cause of ventricular arrhythmia was determined by the doctor, and&#xD;
                  long-term follow-up was not required&#xD;
&#xD;
          5. Cardiac pacemaker implantation&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients with permanent pacemaker implantations due to various causes (including&#xD;
                  bradycardia pacing, implantable cardioverter defibrillator, cardiac&#xD;
                  resynchronization therapy, leadless cardiac pacemaker, etc.)&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
          6. Structural heart disease&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients diagnosed as structural heart disease, including congenital heart&#xD;
                  disease and severe valvular disease (moderate and above valvular stenosis or&#xD;
                  incomplete closure)&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
          7. Pulmonary hypertension&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients diagnosed as pulmonary hypertension&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
          8. Heart failure&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
               -  Patients diagnosed as heart failure&#xD;
&#xD;
               -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
               -  Severe diseases of other systems may affecting the life span of patients&#xD;
&#xD;
          9. Rare diseases of the cardiovascular system&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed as rare diseases in the catalog published by National Health&#xD;
             Commission of the People's Republic of China&#xD;
&#xD;
          -  Patients willing to accept long-term follow-up and regular return visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe diseases of other systems may affecting the life span of patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jia Jia</last_name>
    <phone>861083572283</phone>
    <email>jiajia9985@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Cardiology, Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>北京</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Jia</last_name>
      <phone>861083572283</phone>
      <email>jiajia9985@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 2, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Jianping LI</investigator_full_name>
    <investigator_title>Director of Department of Cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

